Masimo SET
Signal Extraction Technology for accurate pulse oximetry monitoring
Device · EmbeddedCompany source
Company profile
About Masimo
Masimo is a leading global medical technology company that develops, manufactures, and markets a wide range of noninvasive patient monitoring technologies and hospital automation solutions. Founded in 1989, the company pioneered Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo SET®, which has been shown in over 100 independent and objective studies to outperform other pulse oximetry technologies. Masimo's mission is to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications. The company's product portfolio includes advanced monitoring parameters such as hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVI®), RPVi™ (rainbow® PVI), and Oxygen Reserve Index (ORi™). Masimo also offers the Patient SafetyNet™ remote monitoring and clinician notification system, SedLine® brain function monitoring, O3® regional oximetry, and the Root® patient monitoring and connectivity platform. Masimo serves diverse healthcare settings including hospitals, emergency medical services, home healthcare, and consumer health markets. The company's technologies are used by healthcare professionals worldwide to improve patient safety, enhance clinical decision-making, and optimize care delivery. With a strong focus on innovation and clinical evidence, Masimo continues to expand its monitoring capabilities and develop new solutions that address critical healthcare challenges across the continuum of care.
Company description Masimo official website
Primary marketRemote Patient Monitoring & Wearables
Commercial modelCommercial information available on request
Work at Masimo?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- anemia
- carbon monoxide poisoning
- cerebral oximetry
- fluid responsiveness
- hypoxemia
- methemoglobinemia
- sedation monitoring
Who it serves
- Ambulatory Surgery Centers
- Emergency Medical Services
- Health Systems
- Home Healthcare
- Hospitals
Deployment & integration
Embedded · Hybrid deployment with recorded integration context.
Recorded integration context: Root® patient monitoring and connectivity platform enables integration with hospital systems.
Geographic context
MarketsAsia · Europe · Global · Latin America · United States
Company sourceOfficial website
Company milestones
Platform expansion
Continued expansion of rainbow® monitoring parameters, advancement of Patient SafetyNet remote monitoring platform, development of Root® connectivity platform for hospital-wide monitoring integration
Partnerships
Recorded partners
No partners are currently listed.
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Masimo W1
Advanced health tracking watch with continuous monitoring capabilities
Device · EmbeddedCompany source
Radius PPG
Continuous remote patient monitoring system for hospital and home use
Device · HybridCompany source
rainbow SET
Noninvasive monitoring platform for hemoglobin, carboxyhemoglobin, and methemoglobin
Device · EmbeddedCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
HOPFIT: A neuro-cardiovascular monitoring framework for precision sedation, anaesthesia, and resuscitation.Journal of clinical monitoring and computing · Aug 26, 2026
NIRS monitoring during steep trendelenburg in robotic prostatectomy.Journal of clinical monitoring and computing · May 26, 2026
Clinical evaluation of a spot-check ECG for the diagnosis of atrial fibrillation.Heart rhythm O2 · Apr 1, 2026
Response to 'Randomised crossover study on pulse oximeter readings from different sensors in very preterm infants' by Maiwald et al.Archives of disease in childhood. Fetal and neonatal edition · Dec 20, 2024
Pulse Oximetry Performance in Darkly Pigmented Skin: Methodological Concerns.Anesthesia and analgesia · Dec 1, 2024
A plea for enhanced monitoring of depth of sedation in patients who are intubated and ventilated.Critical care (London, England) · Oct 22, 2024
Clinical validation
Clinical-trial records
Clinical Performance of Masimo INVSENSOR00048NCT06289556 · Sponsor · TERMINATED
Clinical Performance of Masimo INVSENSOR00048 (DALI0001)NCT06922461 · Sponsor · TERMINATED
Continuous Versus Intermittent Ward MonitoringNCT06232876 · Sponsor · RECRUITING
Validation of the Masimo Irregular Heartbeat Detection Algorithm in Participants Without Cardiovascular DiseaseNCT07223164 · Sponsor · COMPLETED
Auriculo-Nerve Stimulation on Post-Operative Opioid RequirementNCT05506878 · Sponsor · COMPLETED
Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE)NCT06432881 · Sponsor · COMPLETED
Regulatory
Regulatory records
Masimo SafetyNetDEN200011 · De Novo · Mar 31, 2023
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
improved patient outcomes
through advanced noninvasive monitoring
reduced cost of care
by enabling early detection and intervention
superior performance
in motion and low perfusion conditions compared to conventional pulse oximetry
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Masimo
Recent articles published on Masimo's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Remote Patient Monitoring & Wearables
Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.